摘要
目的：分析口服降糖药在武汉地区的应用情况和发展趋势。方法：采用销售金额、用药频度和限定日剂量为指标的分析方法，对武汉地区32家医院2010～2012年口服降糖药相关数据进行统计分析。结果：口服降糖药总体销售金额和用药频度逐年升高，阿卡波糖和格列齐特等位居前列，中药类应用比例下降。结论：武汉地区32家医院的口服降糖药应用基本合理，口服降糖药的市场前景广阔。
Objective： To analyze the utilization and tendency of oral hypoglycemic agents in some hospitals of Wuhan from 2010 to 2012. Methods： The relative data of oral hypoglycemic agents used in 32 hospitals of Wuhan area during 2010-2012 were analyzed using consumption sum, DDDs and defined daily dose as the indices. Results： The consumption sum of oral hypoglycemic agents was increased year after year; acarbose and gliclazide were widely used and occupied front places among the drugs. However, the percentage of traditional Chinese medicine used for decreasing blood sugar was declined. Conclusion： During 2010-2012, the DDDs value and the consumption sum of oral hypoglycemic agents in Wuhan area are stable and normal, and the application will be further developed.
出处
《中国药师》
CAS
2014年第2期296-300,共5页
China Pharmacist
